[Edaily Reporter KIM SAE-MI ] MEDIPOST CO., LTD.(078160)announced on the 11th that it is offering a cell storage conversion service to existing WOONGJIN Free Life subscribers.

This service allows existing WOONGJIN Free Life subscribers to utilize MEDIPOST CO., LTD.’s cell storage services by converting their existing funeral service plans.

The conversion service consists of two types: an adipose-derived stem cell storage product and an immune cell storage product. The process works as follows: After WOONGJIN Free Life explains the service details and usage procedures and confirms the customer’s intention to use the service, it refers the customer to MEDIPOST CO., LTD., which then handles the contract signing and cell storage procedures.

Medical staff at partner healthcare institutions are responsible for collecting adipose tissue and peripheral blood samples. The collected specimens are then transported to MEDIPOST CO., LTD., where cell isolation, testing, processing, and long-term storage are performed.

A MEDIPOST CO., LTD. official stated, “The combination of WOONGJIN FreeLife’s customer service infrastructure and MEDIPOST CO., LTD.’s cell-related technology and operational capabilities will create synergy,” adding, “We will continue to provide differentiated healthcare services in the future.”

Meanwhile, MEDIPOST CO., LTD. operates adipose-derived stem cell and immune cell storage services through “Lucatree,” its advanced regenerative medicine brand. The company maintains a comprehensive management system covering everything from cell collection to transportation, isolation, testing, and storage, and plans to expand its related business in the future.